Results 131 to 140 of about 17,282 (158)

Cardiovascular Effects of Cannabidiol: From Molecular Mechanisms to Clinical Implementation. [PDF]

Int J Mol Sci
Urlić H, Kumrić M, Pavlović N, Dujić G, Dujić Ž, Božić J.   +5 more
europepmc   +1 more source

The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer's disease. [PDF]

Front Psychiatry
Rao JS, Alejandra Tangarife M, Venegas MM, Forero B, González Tamayo LL, Escobar-Gallego JP, Rodríguez-Soacha DA, Ferreiros A, Mukunda R.   +8 more
europepmc   +1 more source

Behavioral pharmacology of novel synthetic indazole, indole, and benzimidazole cannabinoids in rodents. [PDF]

J Cannabis Res
Shetty RA, Hill RD, McDonald JA, Sumien N, Forster MJ, Gatch MB.   +5 more
europepmc   +1 more source

Characterization of binding kinetics and intracellular signaling of new psychoactive substances targeting cannabinoid receptor using transition-based reweighting method. [PDF]

Elife
Dutta S, Shukla D.
europepmc   +1 more source

Synthesis of Novel Chloro-Benzo [<i>d</i>]imidazole Regioisomers as Selective CB₂ Receptor Agonists: Indirect Functional Evaluation and Molecular Insights. [PDF]

Pharmaceuticals (Basel)
Salazar VZ, Ravanal RB, Soto-Flores J, Sabadini G, González JV, Mella J, Romero-Parra J.   +6 more
europepmc   +1 more source

Adipogenicity-induced human mesenchymal stem cells treated with hemp seed oil stimulate brown-like adipocytes and decrease adipokine levels through the activation of cannabinoid receptor 2 (CB2). [PDF]

J Cannabis Res
Almousa A, Subash-Babu P, Alanazi IO, Alshatwi AA.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CB1 Cannabinoid Receptor Ligands

Mini-Reviews in Medicinal Chemistry, 2005
The CB1 receptor is expressed in the central nervous system and numerous other tissues including heart, lung and uterus and has been recognized as an important therapeutic target for pain, appetite modulation, glaucoma, multiple sclerosis and other indications.
Ganesh A, Thakur, Spyros P, Nikas, Alexandros, Makriyannis   +2 more
openaire   +2 more sources

The Cannabinoid CB1 Receptor in Schizophrenia

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2021
Converging lines of evidence from epidemiological, preclinical, and experimental studies indicate that the endocannabinoid system may be involved in the pathophysiology of schizophrenia and suggest that the cannabinoid CB1 receptor may be a potential therapeutic target.
Faith Borgan, Michelle Kokkinou, Oliver Howes   +2 more
openaire   +3 more sources